Clare London

Clare London

UNVERIFIED PROFILE

Are you Clare London?   Register this Author

Register author
Clare London

Clare London

Publications by authors named "Clare London"

Are you Clare London?   Register this Author

19Publications

764Reads

26Profile Views

Discovery and Pharmacology of a Novel Class of Diacylglycerol Acyltransferase 2 Inhibitors.

J Med Chem 2015 Dec 20;58(23):9345-53. Epub 2015 Nov 20.

Department of Discovery Chemistry, ‡Chemistry Modeling, and Informatics, §In Vitro Pharmacology, ∥In Vivo Pharmacology, ⊥Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, #Basic Pharmaceutical Sciences, and ○Atherosclerosis, Merck & Co., Inc. , 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.jmedchem.5b01345DOI Listing
December 2015

Characterization of a new class of potent inhibitors of the voltage-gated sodium channel Nav1.7.

Biochemistry 2007 Dec 21;46(50):14693-703. Epub 2007 Nov 21.

Department of Ion Channels, Merck Research Laboratories, P.O. Box 2000, Rahway, New Jersey 07065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/bi7018207DOI Listing
December 2007

1-Phenyl-8-azabicyclo[3.2.1]octane ethers: a novel series of neurokinin (NK1) antagonists.

Bioorg Med Chem Lett 2006 Apr 18;16(7):2008-12. Epub 2006 Jan 18.

Department of Medicinal Chemistry, Merck Sharp & Dohme Research Laboratories, The Neuroscience Research Centre, Terlings Park, Harlow, Essex CM20 2QR, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2005.12.069DOI Listing
April 2006

Aminoalkyl phenyl sulfones--a novel series of 5-HT7 receptor ligands.

Bioorg Med Chem Lett 2006 Mar 7;16(5):1255-8. Epub 2005 Dec 7.

The Neuroscience Research Centre, Merck Sharp and Dohme Research Laboratories, Terlings Park, Harlow, Essex CM20 2QR, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2005.11.067DOI Listing
March 2006

Novel N1-(benzyl)cinnamamidine derived NR2B subtype-selective NMDA receptor antagonists.

Bioorg Med Chem Lett 2003 Feb;13(4):693-6

Department of Medicinal Chemistry, Merck Sharp & Dohme Research Laboratories, The Neuroscience Research Centre, Terlings Park, Eastwick Road, Harlow, Essex CM20 2QR, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0960-894x(02)01060-0DOI Listing
February 2003